Viracta

Viracta is a California-based biotechnology company that researches and develops novel therapeutics to treat cancer and virus-affected diseases.

Business Model:

Revenue: $0

Employees: 11-50

Detailed Viracta Information

Geographic Data

Viracta headquarters map

Address: 2533 S. Coast Highway 101

City: Cardiff

State: CA

Zip: 92007

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$50M

Raised Total:

$207M

Metrics

3,294,871Website Global Rank

4,611Website Monthly Traffic

Twitter Followers

Description

Viracta is a California-based biotechnology company that researches and develops novel therapeutics to treat cancer and virus-affected diseases.

Contact Phone:
+18584008470

Contact Email:

Viracta went public on 2/24/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/24/2021

Ticker Symbol:
VIRX

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2012 Venture Round $6.5M
11/2020 Series E $0 aMoon Fund
Latterell Venture Partners
LifeSci Venture Partners
Taiwania Capital
aMoon Fund
Latterell Venture Partners
LifeSci Venture Partners
Taiwania Capital
11/2020 Series E $40M aMoon
Taiwania Capital Management
Latterell Venture Partners
LifeSci Venture Partners
2/2021 IPO -
3/2012 Series B $0 Latterell Venture Partners
Forward Ventures
Lilly Ventures
DeNovo Ventures
Aberdare Ventures
Latterell Venture Partners
Forward Ventures
Lilly Ventures
DeNovo Ventures
Aberdare Ventures
10/2019 Series D 1 - Taiwania Capital Management Corporation
Taiwania Capital Management Corporation
11/2007 Series A 3 $20M Lilly Ventures
Forward Ventures
DeNovo Ventures
Lilly Ventures
4/2020 Debt $150k U.S. Small Business Administration.
4/2017 Series B $0 NantKwest
Forward Ventures
Latterell Venture Partners
Wicklow Capital
NantKwest
Forward Ventures
Latterell Venture Partners
Wicklow Capital
4/2010 Series B 4 $12M Aberdare Ventures
Lilly Ventures
Forward Ventures
DeNovo Ventures
Aberdare Ventures
2/2021 Post-IPO Equity 10 $65M Janus Henderson Investors
Logos Capital
Surveyor Capital
LifeSci Venture Partners
aMoon Fund
Sectoral Asset Management
Ridgeback Capital
BVF Partners
BVF Partners
Serrado Capital
Samsara BioCapital
Janus Henderson Investors
Logos Capital
Surveyor Capital
LifeSci Venture Partners
aMoon Fund
Sectoral Asset Management
Ridgeback Capital
BVF Partners
BVF Partners
11/2021 Post-IPO Debt $0 Oxford Finance LLC
Silicon Valley Bank
Oxford Finance LLC
Silicon Valley Bank
12/2018 Corporate Round $0 Shenzhen Salubris Pharmaceuticals
Shenzhen Salubris Pharmaceuticals
11/2021 Post-IPO Debt 2 $50M Silicon Valley Bank
Oxford Finance LLC
Oxford Finance LLC
Silicon Valley Bank
2/2021 IPO -
11/2020 Series E 4 $40M aMoon Fund
aMoon Fund
10/2019 Series D 1 - Taiwania Capital
Taiwania Capital
12/2018 Corporate Round 1 $10M Shenzhen Salubris Pharmaceuticals
Shenzhen Salubris Pharmaceuticals
4/2017 Series B 4 $18.4M NantKwest
NantKwest
3/2012 Series B 5 $13M
Announced Date Name Price
11/2020 Sunesis Pharmaceuticals

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research